Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Joanna S Remack"'
Autor:
Karina Jin Yoon, Doris A Phelps, Rebecca A Bush, Joanna S Remack, Catherine A Billups, Joseph D Khoury
Publikováno v:
PLoS ONE, Vol 3, Iss 11, p e3629 (2008)
The actin cytoskeleton is a primary determinant of tumor cell motility and metastatic potential. Motility and metastasis are thought to be regulated, in large part, by the interaction of membrane proteins with cytoplasmic linker proteins and of these
Externí odkaz:
https://doaj.org/article/40fa94eba2c04e359db09a3f00034b00
Autor:
Karen S Aboody, Rebecca A Bush, Elizabeth Garcia, Marianne Z Metz, Joseph Najbauer, Kristine A Justus, Doris A Phelps, Joanna S Remack, Karina Jin Yoon, Shanna Gillespie, Seung U Kim, Carlotta A Glackin, Philip M Potter, Mary K Danks
Publikováno v:
PLoS ONE, Vol 1, p e23 (2006)
Patients diagnosed with metastatic cancer have almost uniformly poor prognoses. The treatments available for patients with disseminated disease are usually not curative and have side effects that limit the therapy that can be given. A treatment that
Externí odkaz:
https://doaj.org/article/fbdc182300744ae18ba3c46343dfa818
Autor:
Joseph Najbauer, Monika Wierdl, Seung U. Kim, Mary K. Danks, Marianne Z. Metz, Rebecca A. Bush, Joanna S. Remack, Lyudmila Tsurkan, Karen S. Aboody, K. Jin Yoon, Elizabeth Garcia, Philip M. Potter
Publikováno v:
Cancer Research. 67:22-25
Neural stem cells and progenitor cells migrate selectively to tumor loci in vivo. We exploited the tumor-tropic properties of HB1.F3.C1 cells, an immortalized cell line derived from human fetal telencephalon, to deliver the cDNA encoding a secreted f
Autor:
Samuel A. Wells, Klaus K.-F. Herfarth, Joanna S. Remack, Paul J. Goodfellow, Thomas P. Brent, Ira J. Kodner, Rebecca P. Danam
Publikováno v:
Molecular Carcinogenesis. 24:90-98
The enzyme O6-methylguanine-DNA methyltransferase (MGMT) protects cells from the cytotoxic and mutagenic effects of alkylating agents. Approximately 20% of tumor cell lines lack MGMT activity and are highly sensitive to alkylating agents. In establis
Publikováno v:
Proceedings of the National Academy of Sciences. 94:4348-4353
O 6 -Methylguanine-DNA methyltransferase (MGMT), an enzyme that repairs adducts at O 6 of guanine in DNA, is a major determinant of susceptibility to simple methylating carcinogens or of tumor response to anticancer chloroethylating drugs. To investi
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1217:141-146
Approx. 20% of human tumor cell lines (termed Mer−) are deficient in the DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT; E.C.2.1.1.63). Such cells possess the MGMT gene and promoter sequences but have virtually no mRNA or protein. C
Publikováno v:
Nucleic Acids Research. 22:4614-4619
The DNA repair enzyme, O6-methylguanine DNA methyltransferase (MGMT) is responsible for repair of damage induced by alkylating agents that produce adducts at O6-guanine in DNA. Although the MGMT gene promoter has housekeeping gene promoter characteri
Publikováno v:
Mutation Research/DNA Repair. 255:175-182
Transfection of Chinese hamster ovary (CHO) cells with human DNA has been shown in several laboratories to produce clones which stably express the DNA-repair protein, O6-methylguanine-DNA methyltransferase (MGMT), that is lacking in the parent cell l
Autor:
Joseph Khoury, Joanna S. Remack, Rebecca A. Bush, Karina J. Yoon, Doris A. Phelps, Catherine A. Billups
Publikováno v:
PLoS ONE, Vol 3, Iss 11, p e3629 (2008)
PLoS ONE
PLoS ONE
The actin cytoskeleton is a primary determinant of tumor cell motility and metastatic potential. Motility and metastasis are thought to be regulated, in large part, by the interaction of membrane proteins with cytoplasmic linker proteins and of these
Autor:
Jianjun Qi, Richard E. Lee, Philip M. Potter, M. Jason Hatfield, Joanna S. Remack, Kristopher G. Virga, Mary K. Danks, K. Jin Yoon
Publikováno v:
Molecular cancer therapeutics. 5(6)
Enzyme-prodrug approaches to cancer therapy, theoretically, have the potential to mediate tumor-selective cytotoxicity. However, even if tumor-specific prodrug activation is achieved, enzyme-prodrug systems investigated thus far comprised a single en